We are committed to finding a safe, effective, and patient-friendly therapy for food and pediatric allergy patients

 

OLFUS-VIPES Results

Latest News

DBV Technologies Announces Completion of Recruitment in Global Phase III Study of Viaskin Peanut for the Treatment of Peanut Allergic Children

DBV Announced Results of its 2016 Annual Meeting of Shareholders

Agenda

Société Générale - Conférence Healthcare & Biotechnology

Paris

Scientific congresses

SMi Event

UK

2016 AAAAI Annual Meeting

The 2016 AAAAI Annual Meeting (American Academy of Allergy, Asthma and Immunology) took place in Los Angeles from March 4th to 7th.

Epicutaneous Immunotherapy